News | Artificial Intelligence | December 14, 2020
December 14, 2020 — Imagine being a doctor and having a precocious resident permanently by your side, giving you...

JNM celebrates 60 years of nuclear medicine research. Image courtesy of Society of Nuclear Medicine and Molecular Imaging.
News | Nuclear Imaging | December 14, 2020
December 14, 2020 — The Journal of Nuclear Medicine (JNM) has issued a special supplement commemorating six decades of...

Getty Images
News | Women's Health | December 14, 2020
December 14, 2020 — Among patients with breast cancer treated with radiotherapy, under-recognition of symptoms was...
News | Radiation Dose Management | December 11, 2020
December 11, 2020 — Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose...

Getty Images
News | Breast Imaging | December 11, 2020
December 11, 2020 — Minority women and women in general aged 50-64 in Pennsylvania showed an increased proportion of...

Using 14 points in the lungs, researchers looked for abnormalities and assigned each spot a score out of 3 based on its severity. Adding up all the points, they found the total lung ultrasound score was higher for those who had a worsening outcome of COVID-19. Image courtesy of Umberto Sabatini
News | Coronavirus (COVID-19) | December 11, 2020
December 11, 2020 — For some, COVID-19 can result in severe pneumonia or even death, while others remain purely...

Getty Images
News | Radiation Therapy | December 10, 2020
December 10, 2020 — Physicians did not recognize side effects from radiation therapy in more than half of breast cancer...

Pre-treatment (A-C) and post-treatment (D-F) images after eight cycles of systemic FOLFIRINOX and consolidative chemoradiation. Baseline CA 19-9 was 145 U/ml. Pre-treatment whole body axial fused PET/MRI showed FDG avid lesion in body of pancreas (arrow, A) with SUVmax 7.1 and SUVgluc 8.0. Lesion was hypo-enhancing on axial contrast-enhanced T1-weighted (T1W) MR image (arrow, B) from focused abdominal PET/MRI and on CT (arrow, C). Pre-treatment CT tumor volume was 10.3 cm3. Post-treatment whole body axial fused PET/MRI showed complete metabolic response (arrow D) with SUVmax 1.9 and SUVgluc 1.9. Lesion was indistinct on axial contrast-enhanced T1W MRI (arrow, E) and CT (arrow, F), and there was upstream pancreatic parenchymal atrophy. Post-treatment CT tumor volume was 0.46 cm3. There was normalization of CA 19-9. Relative change in SUVmax (ΔSUVgluc) was -73%, and relative change in SUVgluc (ΔSUVgluc) was -76%. Based on change in tumor size, response was categorized as partial response per RECIST. Relative change in tumor volume (ΔTvol) was -96%. Pathology showed major pathologic response (College of American Pathologists score 1.) Images courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)
News | PET-MRI | December 10, 2020
December 10, 2020 — According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR...
News | Enterprise Imaging | December 09, 2020
December 9, 2020 — UK HealthCare, the campus-based healthcare system for the University of Kentucky, has chosen Hyland...
News | Artificial Intelligence | December 09, 2020
December 9, 2020 — AiCure, an artificial intelligence (AI) and advanced data analytics company focused on improving...

Mixed Reality Viewer technology turns almost any work area into a virtual, interactive space strengthening 3D visualization, interaction and understanding. (Image courtesy of Brainlab).
December 9, 2020 — the digital medical technology company, announced today that over 120 systems have been sold around...

An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University
News | Coronavirus (COVID-19) | December 08, 2020
December 8, 2020 — After recovering from COVID-19, some patients are left with chronic, debilitating pain, numbness or...

Getty Images
News | Radiology Business | December 08, 2020
December 8, 2020 — The medical imaging market size has the potential to grow by $17.64 billion during 2020-2024, and...

Image courtesy of Toshiba/Canon
News | Computed Tomography (CT) | December 08, 2020
December 8, 2020 — For heavy (ex-)smokers, lung cancer screening using low-dose computed tomography (low-dose CT, LDCT...

Getty Images
News | Radiology Imaging | December 08, 2020
December 8, 2020 — Total medical devices industry deals for Q3 2020 worth $98.5B were announced globally, according to...

Getty Images
News | Coronavirus (COVID-19) | December 07, 2020
December 7, 2020 — An analysis of lung tissues from patients with different types of pulmonary fibrosis - including...

Getty Images
December 7, 2020 — The U.S. Food and Drug Administration (FDA) is informing patients and health care providers that...

Images show symptomatic false-negative cancer in a 73-year-old black woman who presented with a palpable abnormality 64 days after negative screening mammography. (a) Negative screening left digital breast tomosynthesis (DBT) mammogram. (b) Diagnostic DBT mammogram shows a new palpable mass (arrow). (c) Spot-compression DBT mammogram enables confirmation of mass (arrow). (d) Ultrasound (US) image shows hypoechoic mass with angular margins. Subsequent US-guided biopsy revealed estrogen receptor- and progesterone receptor-positive and human epidermal growth factor receptor 2-negative invasive ductal carcinoma. Image courtesy of Radiological Society of North America
News | Breast Imaging | December 07, 2020
December 7, 2020 — Breast cancer screening with digital breast tomosynthesis (DBT) offers significant advantages over...
News | Coronavirus (COVID-19) | December 07, 2020
December 7, 2020 — New research* from Zegami, an Oxford based medical image analysis platform, reveals that 29% of...
Videos | PET-CT | December 04, 2020
This is an example of Canon's Advanced intelligent Clear-IQ Engine (AiCE) AI-driven image reconstruction software that...